Summary An oestrogen sensitive rat mammary tumour was grown in two groups of female and one group of male hooded rats. The male group and one of the female groups were supplemented with oestrogen. The tumours grew most rapidly in the female supplemented group. When the tumours reached 1.5 cm in diameter they were harvested and the cell cycle distribution and number of cells actively synthesising DNA (bromodeoxyuridine (BrdU) labelling index) determined in each case. Chemical extracts were prepared from each tumour and the concentration of phosphorus-containing metabolites determined using high resolution NMR spectroscopy. The concentration of phosphocholine was found to correlate strongly with the number of cells in S-phase and the number of cells labelled with BrdU, whilst a highly significant negative correlation was observed between these two parameters and glycerophosphocholine. The concentration of phosphoethanolamine did not correlate with either of these measures of proliferation rate. The concentration of glycerophosphorylethanolamine showed a weak negative correlation with the number of cells in S-phase. Therapy-induced changes in the growth rate of human neuroblastoma (Maris et al., 1985) and breast carcinomata (Sijens et al., 1988; Glaholm et al., 1989) have been shown to be accompanied by changes in the PME content of the tumours. The PME region of NMR spectra from both neuroblastoma and breast tumours is composed primarily of PC and PE (Maris et al., 1985; Smith et al., 1991a) . In vitro studies using cell culture lines have shown that the concentration of these two compounds in confluent populations of tumour cells is much lower than in cells in the logarithmic phase of growth (Daly et al., 1987; Warden & Friedkin, 1985) . These results suggest an association between the concentration of PE and PC and tumour proliferation rate.
intact tissue. The non-invasive nature of NMR spectroscopy enables repeated determinations to be carried out on the same tissue. Typical spectra from tumours contain resonances from nucelotide triphosphate (NTP), inorganic phosphorus (Pi) and an assortment of phosphodiesters and phosphomonoesters (PMEs) including the phospholipid metabolites phosphoethanolamine (PE) and phosphocholine (PC).
PE and PC are substrates for the rate limiting step in the synthetic pathways for phosphatidylcholine (Ptdcho) and phosphatidylethanolamine (Ptdeth) respectively. They are produced by the phosphorylation of choline and ethanolamine by their respective kinase (Vance & Choy, 1979; Tijburg et al., 1989) . PE and PC can also be formed by the action of phospholipase C on Ptdeth and Ptdcho respectively. Thus PE and PC are both anabolites and catabolites of their respective phospholipids.
Therapy-induced changes in the growth rate of human neuroblastoma (Maris et al., 1985) and breast carcinomata (Sijens et al., 1988; Glaholm et al., 1989) have been shown to be accompanied by changes in the PME content of the tumours. The PME region of NMR spectra from both neuroblastoma and breast tumours is composed primarily of PC and PE (Maris et al., 1985; Smith et al., 1991a) . In vitro studies using cell culture lines have shown that the concentration of these two compounds in confluent populations of tumour cells is much lower than in cells in the logarithmic phase of growth (Daly et al., 1987; Warden & Friedkin, 1985) . These results suggest an association between the concentration of PE and PC and tumour proliferation rate.
In the present study we have induced a rat mammary tumour to grow at different rates by exploiting its sensitivity to oestrogen. The concentration of PC, PE, glycerophosphocholine (GPC) and glycerophosphoryethanolamine (GPE) were then determined in extracts from each tumour and compared with proliferative data.
Experimental
Tumours OESHR1 in an oestrogen-sensitive mammary tumour which was originally induced in rats using oestrogen (Senior et al., 1985) . One mm3 pieces of an OESHR1 tumour were implanted into the flanks of two groups of female hooded rats and one group of male rats. The male group and one of the female group (F + ) were supplemented with oestrogen. This was achieved by implanting pellets consisting of a mixture of estrone 15 mg/rat and cholesterol into the necks of the animals. The third female group (F -) was left unsupplemented. When the tumours had grown to about 1.5 cm in diameter they were harvested from each of the groups.
Harvesting of tumours Bromodeoxyuridine (BrdU) was injected (100mg kg-', 8 mg ml-' of saline) into the peritoneum of each animal. Four hours later the animals were anaethetised using halothane and the tumours exposed and freeze clamped using stainless steel tongues pre-cooled in liquid nitrogen. After excision the tumours were ground to a fine powder under liquid nitrogen. Two hundred mg of the ground tissue were used to prepare nuclei as described below. Metabolites were extracted from the remaining powdered tissue.
Extraction of metabolites Metabolites were extracted from tumour tissue using a chloroform/methanol/tris buffer solvent system (Graham et al., 1987) . Briefly, after addition of 10 mmoles of EDTA (0.4 M) per gram of tumour, the tissue was homogenised in an ice-cold mixture of methanol and chloroform (2:1) (3.75 ml g-' tissue) and the suspension left for 60 min at 4'C. Chloroform (1.25 ml g-' tissue) was then added to the mixture followed by 10 mM tris buffer (pH 7.0) (1.25 ml g-' tissue). The mixture was then centrifuged at 1000g for 15 min at 4'C. The aqueous phase was removed and after addition of 2.5 pLM of methylene diphosphonic acid (MDPA) the pH was adjusted to 7.4. 822 T.A.D. SMITH et al. ments were performed under proton-decoupled conditions in a 10 mm probe. The decoupler was gated off between acquisitions. The parameters used for each acquisition were: sweep width 7937 Hz; acquisition time 0.5 ms; repetition time 6 s (We have previously shown that each of the metabolites are fully relaxed after this time (Smith et al., 1991b) ).
Peak assignments were verified in sample extracts by repeating the NMR measurement of pH 7.4 and pH 6.6 with the addition of commercially obtained metabolites. Quantification was carried out by peak area estimation using the spectrometer's integration facility.
Determination of BrdU labelling index Quantification of the percentage of cells labelled with BrdU was carried out using the method of McNally and Wilson (1990) . This involves several steps and is described below.
Dissagregation of tumour tissue A 200 mg sample of the freeze-clamped tumour tissue which had been ground to a powder as described previously (harvesting of tumours) was added to 5 ml of phosphate buffered saline (PBS) and the mixture centrifuged at 300 g for 5 min. The pellet was resuspended in 1 ml of PBS and then drawn repeatedly into a 1 ml pipette tip. This was continued until only connective tissue remained. The suspension was diluted to 5 ml with PBS and then filtered through 35 fLM nylon mesh in a Swinnex holder. The suspended cells were then pelleted by centrifugation at 300 g for 5 min and resuspended in 1 ml of PBS. Nine ml of cold ethanol was added to the cell suspension whilst vortexing. The fixed cells were then stored at 4°C for a minimum of 24 h.
Preparation of nuclei Fixed cells were pelleted by centrifugation at 300 g for 10 min and the pellet resuspended in 10 ml of pepsin solution (0.4 mg ml-' in 0.1 M HCI). The suspension was then incubated for 60 min at 37°C with intermittant shaking. After filtration through 35 piM nylon mesh, the nuclei were pelleted by centrifugation at 500 g. They were then resuspended in 5 ml PBS and counted on a haemocytometer.
Labelling of nuclei
Freshly prepared nuclei were pelleted by centrifugation at 500 g for 5 min and then resuspended in 2 M HCI at a cell density of 1.5 x 106ml-'. The suspension was incubated at room temperature for 30 min to denature the DNA after which 5 ml of PBS was added and the nuclei centrifuged at 500 g for 5 min. The nuclei were then washed in 10 ml of PBS and resuspended in 200yl of labelling solution (PBS containing 0.5% Tween-20, 0.5% foetal calf serum). Ten yl of rat anti-BrdU monoclonal antibody (supernatant, ICR2) was added to the suspension and the mixture incubated in darkness at room temperature. After 60 min the nuclei were washed twice in 10 ml of PBS and then resuspended in 200 ILI of labelling buffer. Ten ll of goat anti-rat IgG (whole molecule) fluorescein conjugate (Sera Labs) was added and the suspension was incubated for 60 min at room temperature to label BrdU-anti-BrdU complexes in the nuclei. The suspension was then washed twice in 5 ml of PBS and the nuclei resuspended in 3ml of PBS containing 10 sgml-' propidium iodide (PI).
Flow cytometry Flow cytometric measurements were made using an Ortho Cytofluorograft 50H with a Lexel argon-ion laser producing 50 mW at 488 nm. Data were acquired and analysed on an Ortho 2150 computer system. DNA content was measured as red fluorescence (> 630 nm) from PI. A display of the peak vs the area of the signal of red fluorescence was used to gate out debris and any clumped nuclei (Ormerod, 1990 (Ormerod et al., 1987) . Regions were set on the histogram to exclude the host cells from the analysis (see Figure 1 ). The labelling index was expressed as the percentage of tumour cells which had taken up BrdU and was estimated from the cytogram of BrdU vs DNA fluorescence (see Figure 2) . The duration of S phase was measured from the movement of BrdU-labelling cells through the cell cycle in the 4 h between labelling with BrdU and removal of the tumour (Begg et al., 1985) . (Figure 4) . The concentration of PC was found to correlate strongly with both LI (R = 0.70, P <0.01) and with the number of tumour Labelling index (%) b cells in S-phase (R = 0.74, P<0.01). These plots are shown in Figures 5a and b respectively. Figures 6a and b The prominent metabolites observed in the PME and PDE regions of 31P NMR spectra extracts from the OESHR1 rat mammary tumour are the same as those found in human breast carcinoma (Smith et al., 1991a) . The principle component of the PME region of spectra from the rat mammary tumour is PE. The presence of high concentrations of this compound has been observed in several different tumours (Proietti et al., 1986; Corbett et al., 1987; Evanochko et al., 1984) . However, its presence in RIFI (Evanochko et al., 1984) and Friend Leukaemic cells (Proietti et al., 1986 ) in culture appears to be dependent on the presence of ethanolamine in the culture medium. In the absence of the latter from the median PE was not detected in either cell line. PC was also detected in the PME region of each tumour. GPC and GPE are the major water soluble components of the PDE region of the tumour. These two compounds are degradative products of PtdCho and PtdEth respectively and are produced by the action of phospholipase D on these two phospholipids. The source of high concentrations of GPE and GPC sometimes observed in tumours is controversial. Evanochko et al. (1984) showed that with increasing size and hence increasing necrotic content, the contribution of GPC and GPE in RIF-l tumours increased. Based on this finding they suggested that GPC and GPE are produced in areas of necrosis as a consequence of phospholipid degradation. However, two pieces of work have shown that treatment of tumours with substances which induce necrosis, i.e. interferon (Proietti et al., 1986) and tumour necrosis factors (Podo et al., 1987) , results in a decrease in the intra-tumour concentration of these two compounds. Further, in an earlier paper (Smith et al., 1991b) we showed that some breast tumours which histologically did not show necrosis contained appreciable concentrations of GPC and GPE.
The presence of PE and PC in the tumours may reflect their role as phospholipid precursors. Several reports have shown that increased PC levels in exponentially growing cells when compared to confluent cells parallel increased activity of choline kinase in these cells (Warden & Friedkin, 1985; Paddon et al., 1982; Warden & Friedkin, 1984) . The higher concentration of this metabolite in the more rapidly proliferating tumours in the study may be consequence of upregulation of choline kinase in response to demands from the cell for increased phospholipid synthesis.
The phospholipid composition of cell membranes is maintained by a balance between their synthesis and degradation (Dawson, 1973) . In the present work we have shown that in addition to an increase in PC there is a decrease in the GPC content of tumours with increasing numbers of cells undergoing active DNA synthesis. The synthesis of Ptdcho is most rapid in cells during S-phase (Bergeron et al., 1970 (Berridge, 1987) . Evidence suggests that the hydrolysis of PtdCho and in some cases PtdEth may also be involved in initiating and sustained a growth signal (Billah & Anthes, 1990) . The exposure of several cell types to tumour promoters results in the hydrolysis of PtdCho (Guy & Murray, 1982; Besterman et al., 1986) . Thus, Guy and Murray (1982) showed that phorbol diesters cause stimulation of PtdCho turnover in HeLa cells with a consequent rise in the concentration of PC. Besterman et al. (1986) showed that in addition to phorbol diesters, serum and platelet derived growth factor (PDGF) stimulate the hydrolysis of PthCho produced DAG and PC in preadipocytic cells (3T3-L1) within minutes of cell exposure. More recently, Martinson et al. (1989) have shown that the increase in DAG concentration resulting from stimulation of astrocytoma cells with phorbol diesters and carbochol is derived exclusively from PtdCho. Although the hydrolysis of PtdEth in response to growth stimulus is considered to be less important than that of PtdCho (Billah & Anthes 1990; Kiss & Anderson, 1989) in some cells e.g. cultured rat mesangial cells, interleukin-1 generates transmembrane signals by the hydrolysis of PtdEth (Kester et al., 1989) . Thus the choice of substrate for phospholipase C may be dependent on the cell type. One study has shown that oestrogen stimulates the phospholipase C hydrolysis of phospholipids in MCF 7 breast tumour cells (Freter et al., 1986) . In the present study the concentration of PC showed a highly significant correlation with the percentage of tumour cells undergoing DNA synthesis. This may be a consequence of enhanced phospholipase C induced hydrolysis of PtdCho occurring in the more rapidly growing tumours when compared with the less prolific tumours. In summary, we have shown a strong association between the proliferation rate of a rat mammary tumour and the PC and GPC content of the tumour. The higher concentration of PC in the more rapidly proliferating tumours when compared with the slower growing ones may be a consequence of its more rapid synthesis via choline kinase activity or/and a more rapid rate of degradation of PtdCho by phospholipase C as part of an intracellular signalling scheme. We are currently investigating these two possibilities.
